Rethinking heart-lung support: We focus on the essential requirements of patients and their treating physicians in situations where extracorporeal support is critical. With our innovations and solutions, we redefine the field of Extracorporeal Life Support (ECLS and ECMO) –
full attention, strict focus, easy access.
Total raised: $6.81M
Founded date: 2013
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 24.04.2017 | - | $810K | - | finsmes.co... |
| 10.02.2016 | Series A | $6M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 25.07.2017 | Hemovent r... | German medtech startup Hemoven... | - | Mary Lorit... | tech.eu/br... |
| 21.07.2017 | Hemovent E... | Hemovent GmbH, an Aachen, Germ... | Germany | - | finsmes.co... |
| 24.04.2017 | Hemovent R... | Hemovent GmbH, an Aachen, Germ... | Germany | - | finsmes.co... |
| 10.02.2016 | Hemovent C... | Hemovent GmbH, an Aachen, Germ... | Germany | - | finsmes.co... |